Greater Biosimilar Use Could Save U.S. $133 Billion in 2025
From a STAT opinion piece by Juliana M. Reed, executive director of the Biosimilars Forum: "Biologic medicines are some of the most important drugs in the world. They are also among the most expensive. Biosimilars are FDA-approved treatments that are similar to...
Blood Test to Determine Colon Cancer Gets FDA Approval
On July 29, the Food and Drug Administration approved a first-of-its-kind blood test determined to be 83% effective at detecting colon cancer. Called Shield, the noninvasive test was authorized for use by people aged 45 and older with an “average risk” of the...
MedBen Debit Card Offers Savings and Convenience
Offering your plan members a flexible spending account (FSA) option is not only an effective way to help them lower their health care spend (qualified purchases are made using tax-free dollars), but by adding a MedBen debit card, it's a convenient way to do it! The...
FTC Accuses Major PBMs of Overcharging Clients
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled "The Powerful Middlemen...
Finding the Right Reimbursement Balance by Exploring the “Alternatives”
A new survey on health and benefit strategies for 2025 finds that one-third of large employers will offer an "alternative medical plan" to steer employees to quality, cost-effective care. At MedBen, nearly half of our clients have implemented alternative reimbursement...
Nearly Half of U.S. Cancer Deaths Linked to Modifiable Risk Factors
According to a study by the American Cancer Society, four out of ten cancer cases and almost half of cancer deaths in U.S. adults aged 30 and older are associated with modifiable risk factors. In 2019, these factors were linked to over 700,000 new cancer cases and...
What Is Subrogation, and Why Does It Matter to Your Plan?
If one of your plan members is injured as the result of an accident, it's possible that subrogation may be necessary. Subrogation is a recovery process in which medical claim costs resulting from the injury, initially covered by the employer, are reimbursed from a...
Rise in Claims Related to Heart Disease Underlines Importance of Preventive Care
Cardiovascular disease (CVD) has risen to second place on the list of top stop-loss reimbursements, according to Sun Life's annual report of high-cost claims – the first time the condition has ranked so high. As in past years, the report underlines the...
Supreme Court Overturns the Chevron Deference Doctrine (and Why You Should Care)
Last month, in a 6 to 3 decision, the U.S. Supreme Court overturned the “Chevron Deference” doctrine. The Chevron Deference is a principle of administrative law that has required courts to defer to how regulatory agencies interpret federal statutes (legislation...
Proposed Biosimilar Policy Change Great News for MedBen Rx Clients
The Food and Drug Administration is considering a change to its biosimilar policy that would greatly speed up their approval process – which, if enacted, would be a big win for MedBen Rx clients who are already reducing their prescription drug spend through...
Are Your Members Using All the Features Available on the MedBen Access App?
If your plan members haven't downloaded the MedBen Access mobile app, they're missing out! Not only does the app provide timely claims and benefits information, it offers a variety of tools to help members better manage their benefits. Drug pricing comparison. The...
Download the 2024 MedBen Client Report Now!
The 2024 MedBen Client Report is now available to download! In addition to showing how our proven solutions consistently lower client spend, this year's report also spotlights innovations that make these solutions even better. As Chairman & CEO Kurt Harden...